- In April 2023, Nova Eye Medical Ltd. obtained FDA 510(k) clearance for its canaloplasty device, iTrack Advance, designed to lower intraocular pressure (IOP) in adult patients with primary open-angle glaucoma
- In August 2022, Glaukos Corp. received FDA 510(k) clearance for iStent Infinite, a standalone device for reducing elevated IOP in primary open-angle glaucoma patients
- In July 2022, iSTAR Medical entered a strategic partnership with AbbVie to expand AbbVie's portfolio of glaucoma treatments, offering patients additional care options
- In June 2022, AbbVie announced a USD 60 million deal for the rights to acquire iSTAR Medical, a Belgian firm developing the minimally invasive MINIject glaucoma device, now in a U.S. premarket approval study. AbbVie is collaborating on the development and commercialization of the device
- In June 2022, Iridex Corporation secured regulatory approval from China’s National Medical Products Administration (NMPA) to market and sell its Cyclo G6 platform for glaucoma treatment
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Glaucoma Drainage Device, Traditional Surgery Devices, Diamond Knives, Laser Systems, and Others), Target (Trabecular Meshwork, Suprachoroidal Space, and Others), Surgery Type (Conventional Glaucoma Surgeries, Minimally Invasive Glaucoma Surgeries, and Laser Surgery), End-User (Eye Hospitals, Ophthalmology Clinics, and Outpatient Surgical Centres) – Industry Trends and Forecast to 2032
.
The Global Glaucoma Surgery Devices Market size was valued at USD 3.01 USD Billion in 2024.
The Global Glaucoma Surgery Devices Market is projected to grow at a CAGR of 8.94% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
